Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Hyperinsulinemic patients with breast cancer may be responsive to metabolism-targeting treatments

Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments.

20 May 2022

A step-by-step plan to create a digital twin of the human immune system

An article published May 20 in Nature Digital Medicine provides a step-by-step plan for an international effort to create a digital twin of the human immune system.

20 May 2022

Islet cell transplant program offers an effective treatment for patients with hard-to-control Type 1 diabetes

After 20 years of perfecting their technique, the team behind the largest islet cell transplant program in the world reports the procedure is a safe, reliable and life-changing treatment for people with hard-to-control diabetes.

19 May 2022

How does diet affect COVID-19?

Scientists review the current research on how changes in diet can affect infection with SARS-CoV-2.

19 May 2022

Gestational diabetes mellitus in overweight and obese pregnant women may increase COVID-19 severity

Researchers reported that gestational diabetes mellitus and obesity were associated with severe COVID-19.

18 May 2022

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.

18 May 2022

Patients, doctors, insurers agree: Prior approvals for treatment should come faster

Andrew Bade, who was diagnosed with Type 1 diabetes nearly two decades ago, is accustomed to all the medical gear he needs to keep his blood sugar under control.

17 May 2022

Scientists examine the impact of herpesviruses on (pre)diabetes

Scientists have recently analyzed the association between herpesviruses and type 2 diabetes. This study is available in the journal Diabetologia.

15 May 2022

Novel approach allows islet transplants to survive and control diabetes

In type 1 diabetes, an autoimmune response attacks the pancreas's insulin-producing beta cells, leading to marked fluctuations in blood sugar levels. Lifelong daily insulin treatments are standard for patients, but replacing lost beta cells through transplants of islets, a group of cells in the pancreas, represents an attractive option.

13 May 2022

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

In a new study, a team of researchers from the University of Missouri, Georgia Tech and Harvard University has demonstrated the successful use of a novel Type 1 diabetes treatment in a large animal model.

13 May 2022

The potential role of the gut microbiome in modifying patient responses to statin therapy

Researchers discovered strong links between human gut microbiome makeup and statin on- and off-target effects, probably beneficial in medication tailoring.

13 May 2022

Study shows how co-transplanting islet cells with SA-FasL-microgels reverses diabetic symptoms

Islet cell transplants are a promising treatment that can cure difficult-to-treat type 1 diabetes. The cells, taken from a donor pancreas, provide patients with a sustainable and tightly controlled source of insulin.

13 May 2022

Hormonal shift during menopause changes women’s blood metabolite profile

In midlife, the risk of cardiometabolic diseases increases in women more rapidly than in men. A study performed at the Faculty of Sport and Health Sciences of the University of Jyväskylä shows that changes in blood metabolite profile accompany the shift in sex hormone levels during menopause.

13 May 2022

Worldwide study of diverse populations sheds new light on how genes contribute to type 2 diabetes

Ongoing worldwide research of diverse populations by an international team of scientists, including a University of Massachusetts Amherst genetic epidemiologist, has shed important new light on how genes contribute to type 2 diabetes.

12 May 2022

Daily blueberry intake may lower the chances of developing late-life dementia

The old adage says that an apple a day keeps the doctor away, but new research from the University of Cincinnati shows the potential benefit of a different fruit for your health.

11 May 2022

Rutgers study identifies key protein for brain stem cell longevity

A receptor that was first identified as necessary for insulin action, that also is located on the neural stem cells found deep in the brains of mice, is pivotal for brain stem cell longevity, according to a Rutgers study, a finding that has important implications for brain health and future therapies for brain disorders.

11 May 2022

Insulin News and Research

Further Reading

Hyperinsulinemic patients with breast cancer may be responsive to metabolism-targeting treatments

A step-by-step plan to create a digital twin of the human immune system

Islet cell transplant program offers an effective treatment for patients with hard-to-control Type 1 diabetes

How does diet affect COVID-19?

Gestational diabetes mellitus in overweight and obese pregnant women may increase COVID-19 severity

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Patients, doctors, insurers agree: Prior approvals for treatment should come faster

Scientists examine the impact of herpesviruses on (pre)diabetes

Novel approach allows islet transplants to survive and control diabetes

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

The potential role of the gut microbiome in modifying patient responses to statin therapy

Study shows how co-transplanting islet cells with SA-FasL-microgels reverses diabetic symptoms

Hormonal shift during menopause changes women’s blood metabolite profile

Worldwide study of diverse populations sheds new light on how genes contribute to type 2 diabetes

Daily blueberry intake may lower the chances of developing late-life dementia

Rutgers study identifies key protein for brain stem cell longevity

The glycemic index falls short in helping Americans achieve dietary recommendations

Neuroscientists discover a new facet to caloric restriction that dramatically extends life span

Is type 1 diabetes likely to rise after the COVID pandemic?

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News